Roche Holding AG (RHHBY)
32.81
+0.16
(+0.49%)
USD |
OTCM |
May 17, 16:00
Roche 1 Year Total Returns (Daily): -14.22% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -14.22% |
| May 16, 2024 | -13.53% |
| May 15, 2024 | -17.85% |
| May 14, 2024 | -19.11% |
| May 13, 2024 | -20.67% |
| May 10, 2024 | -18.53% |
| May 09, 2024 | -19.18% |
| May 08, 2024 | -20.75% |
| May 07, 2024 | -20.26% |
| May 06, 2024 | -21.28% |
| May 03, 2024 | -21.46% |
| May 02, 2024 | -22.79% |
| May 01, 2024 | -21.09% |
| April 30, 2024 | -20.85% |
| April 29, 2024 | -19.49% |
| April 26, 2024 | -18.59% |
| April 25, 2024 | -21.58% |
| April 24, 2024 | -19.82% |
| April 23, 2024 | -17.60% |
| April 22, 2024 | -18.47% |
| April 19, 2024 | -17.62% |
| April 18, 2024 | -18.83% |
| April 17, 2024 | -18.90% |
| April 16, 2024 | -18.74% |
| April 15, 2024 | -17.80% |
| Date | Value |
|---|---|
| April 12, 2024 | -17.26% |
| April 11, 2024 | -14.98% |
| April 10, 2024 | -16.31% |
| April 09, 2024 | -16.34% |
| April 08, 2024 | -17.62% |
| April 05, 2024 | -15.28% |
| April 04, 2024 | -11.35% |
| April 03, 2024 | -9.03% |
| April 02, 2024 | -8.90% |
| April 01, 2024 | -7.25% |
| March 28, 2024 | -4.73% |
| March 27, 2024 | -7.14% |
| March 26, 2024 | -7.85% |
| March 25, 2024 | -7.91% |
| March 22, 2024 | -7.66% |
| March 21, 2024 | -8.46% |
| March 20, 2024 | -3.36% |
| March 19, 2024 | -4.65% |
| March 18, 2024 | -4.48% |
| March 15, 2024 | -2.06% |
| March 14, 2024 | -2.42% |
| March 13, 2024 | -2.42% |
| March 12, 2024 | 1.91% |
| March 11, 2024 | 0.35% |
| March 08, 2024 | 0.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-27.97%
Minimum
Mar 27 2023
46.51%
Maximum
May 15 2020
7.10%
Average
9.38%
Median
Sep 30 2021
1 Year Total Returns (Daily) Benchmarks
| Novartis AG | 5.16% |
| Pfizer Inc | -17.67% |
| ADC Therapeutics SA | 54.72% |
| Lonza Group Ltd | -7.45% |
| Sarepta Therapeutics Inc | -11.69% |